Featured Archives - Page 21 of 48 - aHUS Alliance Action

Ravulizumab costs less over a life time

Post author:ahusalliance
Post published:November 23, 2020
Post category:Featured
Post comments:0 Comments

Article No 394 23 November 2020 In an article on 16 October 2020 (No 388) aHUS Global Action derived a cost…

Atypical HUS & #Nephrology #SoMe

Post author:ahusalliance
Post published:November 15, 2020
Post category:Featured
Post comments:0 Comments

Harnessing the power of Nephrology Social Media - the aHUS Alliance looks back at KidneyWeek 2020 and its ability to inform & engage patient groups as well as medical professionals. How might Patient Experiences become better integrated to improve outreach and understanding for all stakeholders and initiatives?

Advancements in mRNA – an approach to COVID-19 Vaccines

Post author:Linda Burke
Post published:November 9, 2020
Post category:Featured
Post comments:0 Comments

Pfizer and BioNTech press release 9 Nov 2020 announced positive announcement for their COVID-19 vaccine candidate. In the rapidly changing pandemic landscape, the aHUS Alliance provides compiled info & resources for background on mRNA and its potential approach to prevent disease.

IPNA WebMaster for Nov 7th: Focus on HUS

Post author:ahusalliance
Post published:November 3, 2020
Post category:Featured
Post comments:0 Comments

Join in this 7 November 2020 IPNA endorsed webinar on HUS, number 17 in the IPNA Web Master series. Pediatricians as well as adult & pediatric nephrologists are invited to deep dive into the topic presented by Dr Sidharth Kumar Sethi - HUS: Newer Developments in Pathology & Treatment.